CHARA Approved for a $50,000 Award by the Patient-Centered Outcomes Research Institute

​July 28, 2016 – CHARA has been approved for a $50,000 award by the Patient-Centered Outcomes Research Institute (PCORI) to develop a research study that focuses on colorectal cancer screening through the Tier III Pipeline to Proposal award.
 
CHARA will use the funds provided through PCORI’s Pipeline to Proposal Awards program to build a partnership of individuals and groups who share a desire to advance patient-centered outcomes research focused on colorectal cancer screening.
 
Pipeline to Proposal Awards enable individuals and groups that are not typically involved in clinical research to develop the means to develop community-led funding proposals focused on patient-centered comparative effectiveness research (CER). Established by the non-profit PCORI, the program funds three tiers of awards that help individuals or groups build community partnerships, develop research capacity, and hone a comparative effectiveness research question that could become the basis of a research funding proposal to submit to PCORI or other health research funders.
 
Through this year long funding period, CHARA will be refining a CER question aimed at addressing colorectal cancer and will develop this into a research proposal with guidance from expert advisors, PCORI program officers, community stakeholders and patients. The initial CER questions were created during our Tier II award period and framed around health priorities identified by the community. CHARA will also continue to strengthen partnerships and support local health efforts.
 
“The Pipeline to Proposal Awards program is a manifestation of PCORI’s commitment to the meaningful involvement of patients, caregivers, clinicians, and other stakeholders in all our research endeavors,” said Jean Slutsky, PA, MSPH, PCORI's Chief Engagement and Dissemination Officer. “It provides support to those who may not otherwise have an opportunity to contribute to the field of comparative effectiveness research. We’re pleased to follow the awardees’ progress as they develop partnerships and begin to form research questions.”
 
PCORI is an independent, non-profit organization authorized by Congress in 2010 to fund comparative effectiveness research that will provide patients, their caregivers, and clinicians with the evidence needed to make better-informed health and healthcare decisions. PCORI is committed to seeking input from a broad range of stakeholders to guide its work.